latest news releases from the newsroom
Interpharm Holdings, Inc.
Interpharm Announces $10 Million Financing With Aisling Capital
HAUPPAUGE, N.Y., Sept. 15, 2006 (PRIMEZONE) -- Interpharm Holdings, Inc. (AMEX:IPA), a manufacturer and distributor of generic pharmaceuticals, today announced it has completed a $10 million capital financing with Aisling Capital II, L.P. ("Aisling"). A full description of the Aisling stock purchase agreement, pursuant to which Aisling purchased $10 million Series C-1 Convertible Preferred Stock ("Series C-1") and warrants will be available in a Current Report on Form 8-K which will be filed by Interpharm with the SEC on September 15, 2006. The Series C-1 stock is convertible into an aggregate of approximately 6.5 million shares of Interpharm common stock at $1.53 per share, and the warrants, which have an exercise price of $1.639 per share, are exercisable for an aggregate of 2,281,914 shares of common stock.
GlassKote USA, LLC
GlassKote USA Launches `Extreme Granite' at GlassBuild America
BRIDGEPORT, Conn., Sept. 15, 2006 (PRIMEZONE) -- GlassKote USA is pleased to announce the launch of Extreme Granite(tm) at this year's GlassBuild America Show in Las Vegas, September 19-21, 2006. Extreme Granite is a new decorative finish for glass that builds on the appearance of natural granite by adding unusual colors and textures that just don't occur in stone. GlassKote USA will offer this new material for commercial and residential applications where the look of granite, color flexibility and the functionality of glass come together to provide a unique surface.
Pulitzer Prize-Winning Author to Present At Marygrove College
DETROIT, Sept. 15, 2006 (PRIMEZONE) -- Marygrove College hosts the return of Detroit-area native and second-generation Greek-American author Jeffrey Eugenides on Sunday, October 29, 2006, at 4 p.m. in the Madame Cadillac Building in Detroit. In a presentation titled "'All Swirl and Hubbub': Jeffrey Eugenides and Detroit," he will read from his 2003 Pulitzer Prize-winning novel Middlesex. A reception and book signing will follow the presentation. It is free and open to the public.
Nobel Biocare to Establish Chair at UCLA School of Dentistry
YORBA LINDA, Calif., Sept. 15, 2006 (PRIMEZONE) -- Nobel Biocare (Other OTC:NBCHF), the world leader in innovative esthetic dental solutions, today announced it will contribute $2.5 million to the UCLA School of Dentistry, California, to create an endowed chair in surgical implant dentistry. The Chair will promote education and training of students, faculty and national and international dental practitioners as well.